Infectious disease
Point-of-care testing is a critical tool in the battle against COVID-19, and researchers in Indiana are working around the clock to deliver rapid tests with high specificity.
Regeneron will distribute REGN-COV-2 in the U.S. and Roche will handle distribution outside the U.S.
A study published in JAMA Cardiology back on July 27 is now raising concern in the medical community, as many coronavirus patients are exhibiting signs of heart damage, despite being asymptomatic.
Shortly before COVID-19 patients’ conditions advance from moderate to severe, their levels of type I interferon (IFN) are present in the bloodstream drop.
Despite the urgent need for more research into the coronavirus, the New York Times reported on August 14 that there have been numerous testing delays, staffing shortages and space constraints tying up the process.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 19, 2020.
The 11-person team at Codagenix may be tiny, but it has big plans for the company’s new COVID-19 vaccine.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 17, 2020.
“Today’s announcement puts another building block in place as the Nation moves toward a safe and effective COVID-19 vaccine,” stated Robert Redfield, director of the U.S. Centers for Disease Control and Prevention.
Phase III clinical trials for Russia’s Sputnik V vaccine for COVID-19 began Wednesday, one day after the Russia Direct Investment Fund (RDIF) launched a new website to share the details of the vaccine with the public and scientists around the world.
PRESS RELEASES